As of Apr 21
| -0.56 / -0.48%|
The 22 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 118.00, with a high estimate of 144.00 and a low estimate of 75.00. The median estimate represents a +1.11% increase from the last price of 116.70.
The current consensus among 27 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.